Day 3 / Aakash Desai, Andrea Necchi, Bishal Gyawali, Erika Ruiz-Garcia, Fagr Aboumadawy, Ippokratis Korantzis, ...
AstraZeneca's Imfinzi combined with Pfizer's Padcev cut the risk of death in muscle-invasive bladder cancer patients by 42%, ...
Jesse Heffels on MSN
A flipping challenge between two brothers
Flipping challenges test balance, coordination, body control, and the ability to execute acrobatic movements with proper ...
Msd announced today that the European Commission has approved pembrolizumab in combination with enfortumab vedotin, as neoadjuvant treatment and subsequently, after radical cystectomy, as adjuvant ...
In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...
ARE you worried about your health as we edge closer to winter? It is completely normal to feel a bit more vulnerable as ...
A new narrative review proposes that periodontal inflammation may amplify genitourinary vulnerability during and after ...
Police are urging parents to talk with their children about a dangerous social media trend called the “Benadryl Challenge” after a St. Marys Middle School student was taken to a hospital.
The Chosun Ilbo on MSN
Posterior approach robotic prostatectomy reduces urinary complications
As South Korea enters a super-aged society, prostate cancer—the leading cancer among men—has seen nearly all prostate removal ...
Researchers from the Shenyang Institute of Automation (SIA) of the Chinese Academy of Sciences have developed an ...
A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose people with bladder cancer more accurately than current standard methods. The test ...
Which bladder control supplements are best? Involuntary urination is a scary condition for most people, and specific medical issues, stress or aging can lead to incontinence. But there are steps you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results